Hobart Private Capital, LLC Thermo Fisher Scientific Inc. Transaction History

Hobart Private Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 11, 2024	BUY	$435.06 - $527.66 $49,161 - $59,625	113 Added 7.89%	1,546 $720 Million
Q3 2020 Mar 11, 2024	BUY	$359.77 - $441.52 $55,404 - $67,994	154 Added 12.04%	1,433 $633 Million
Q2 2020 Mar 11, 2024	BUY	$275.2 - $362.34 $47,609 - $62,684	173 Added 15.64%	1,279 $463 Million
Q1 2020 Mar 11, 2024	SELL	$255.3 - $340.05 $58,463 - $77,871	-229 Reduced 17.15%	1,106 $314 Million
Q4 2019 Mar 11, 2024	BUY	$271.93 - $328.04 $363,026 - $437,933	1,335 New	1,335 $434 Million
Q3 2019 Mar 11, 2024	BUY	$268.46 - $305.43 $11,275 - $12,828	42 Added 3.82%	1,142 $333 Million
Q2 2019 Mar 11, 2024	BUY	$257.51 - $295.55 $283,261 - $325,105	1,100 New	1,100 $323 Million

2,904

342M

2.02M

2.73M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $167B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hobart Private Capital, LLC with notifications on news.